Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Cleva

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Drug Discovery Today|July 10, 2003
Chemical substructures in drug discoveryCédric Merlot, Daniel Domine, Christophe Cleva, et al.
Bioorganic & Medicinal Chemistry Letters|May 21, 2010
Discovery of a novel series of CXCR3 antagonistsStefano Crosignani, Marc Missotten, Christophe Cleva, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Optimization of the Central Core of Indolinone-Acetic Acid-Based CRTH2 (DP2) Receptor AntagonistsStefano Crosignani, Catherine Jorand-Lebrun, Patrick Page, et al.
Journal of Medicinal Chemistry|March 6, 2008
Discovery of a new class of potent, selective, and orally bioavailable CRTH2 (DP2) receptor antagonists for the treatment of allergic inflammatory diseasesStefano Crosignani, Patrick Page, Marc Missotten, et al.
Journal of Medicinal Chemistry|September 16, 2011
Discovery of potent, selective, and orally bioavailable alkynylphenoxyacetic acid CRTH2 (DP2) receptor antagonists for the treatment of allergic inflammatory diseasesStefano Crosignani, Adeline Prêtre, Catherine Jorand-Lebrun, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of a Novel Series of CRTH2 (DP2) Receptor Antagonists Devoid of Carboxylic AcidsStefano Crosignani, Catherine Jorand-Lebrun, Gordon Campbell, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Drug Discovery Today|July 10, 2003
Chemical substructures in drug discoveryCédric Merlot, Daniel Domine, Christophe Cleva, et al.
Bioorganic & Medicinal Chemistry Letters|May 21, 2010
Discovery of a novel series of CXCR3 antagonistsStefano Crosignani, Marc Missotten, Christophe Cleva, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Optimization of the Central Core of Indolinone-Acetic Acid-Based CRTH2 (DP2) Receptor AntagonistsStefano Crosignani, Catherine Jorand-Lebrun, Patrick Page, et al.
Journal of Medicinal Chemistry|March 6, 2008
Discovery of a new class of potent, selective, and orally bioavailable CRTH2 (DP2) receptor antagonists for the treatment of allergic inflammatory diseasesStefano Crosignani, Patrick Page, Marc Missotten, et al.
Journal of Medicinal Chemistry|September 16, 2011
Discovery of potent, selective, and orally bioavailable alkynylphenoxyacetic acid CRTH2 (DP2) receptor antagonists for the treatment of allergic inflammatory diseasesStefano Crosignani, Adeline Prêtre, Catherine Jorand-Lebrun, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of a Novel Series of CRTH2 (DP2) Receptor Antagonists Devoid of Carboxylic AcidsStefano Crosignani, Catherine Jorand-Lebrun, Gordon Campbell, et al.
Pageof 1